On this page
Conflicting evidence: a Bayesian network meta-analysis supports verum acupuncture superiority over sham, while a WHO systematic review and two individual trials find no significant difference.
- Efficacy of acupuncture versus sham for chronic low back painSupporting: A Bayesian network meta-analysis concluded that verum acupuncture is more effective than sham for chronic low back pain. [4]Opposing: A WHO systematic review found little or no difference between needling therapies and sham, and two individual randomized trials (electroacupuncture in older adults and electroacupuncture vs sham) reported no statistically significant superiority of acupuncture over sham or placebo. [2, 15, 16]
Board Review — High Yield
- •Acupuncture reduces pain by 1.2-1.6 points (0-10 scale) vs no intervention at 2 weeks to 3 months, and by 9.4 points (0-100 NRS) vs conventional therapy.
- •The acupuncture evidence is based on a single trial of 60 adults with chronic nonspecific low back pain (median age 47, 63% women).
- •Meta‑analysis shows acupuncture reduces pain vs. no intervention (MD -1.21 at 2 weeks) and vs. usual care (MD -1.35 at 3 months), but certainty is low to very low.
- •Serious adverse events attributable to acupuncture for chronic low back pain occur in <1% of patients, based on the largest pragmatic trial in older adults [28].
- •Certainty of evidence is low to very low for most outcomes [2][36], driven by performance bias and imprecision.
- •Acupuncture is recommended as a first-line nonpharmacologic treatment for chronic low back pain by ACP (strong recommendation, moderate-quality evidence) and OPTIMa guidelines.
Deep Dive — Evidence Details
Clinical Bottom Line
- ▸Acupuncture reduces pain by 1.2-1.6 points (0-10 scale) vs no intervention at 2 weeks to 3 months, and by 9.4 points (0-100 NRS) vs conventional therapy.
- ▸Effect over sham acupuncture is small (3.5 points on 0-100 NRS), limiting the conclusion of specific efficacy.
- ▸ACP gives a strong recommendation for acupuncture as initial nonpharmacologic treatment for chronic low back pain, based on moderate- to low-quality evidence.
Acupuncture reduces pain and improves function in adults with chronic low back pain compared with no intervention (pain reduction: MD -1.21, 95% CI -1.50 to -0.92 on a 0-10 scale at 2 weeks [2]A1c) and compared with usual care (pain MD -1.35, 95% CI -1.86 to -0.84 at 3 months [2]A1c), though the effect versus sham acupuncture is small (relative effect 3.5 points on a 0-100 NRS [6]B2a). The American College of Physicians strongly recommends acupuncture as initial nonpharmacologic treatment for chronic low back pain [1]A1c, while the WHO systematic review found low to very low certainty evidence for these benefits [2]A1c. Treatment duration should be at least 5 weeks to achieve 80% of the maximum analgesic effect [6]B2a.
Pearl: Acupuncture offers a clinically meaningful advantage over no treatment or usual care; the absolute benefit is modest and evidence certainty is low, but given the favorable safety profile, it is a reasonable first-line nonpharmacologic option.
Population and Setting
- ▸The acupuncture evidence is based on a single trial of 60 adults with chronic nonspecific low back pain (median age 47, 63% women).
- ▸Setting was outpatient; exclusion of specific causes (e.g., radiculopathy, disc herniation) limits applicability to those subgroups.
- ▸Broader CLBP trials show similar demographics, but direct acupuncture data remain sparse.
Having established the clinical bottom line, the evidence for acupuncture in chronic low back pain (CLBP) is grounded in a specific outpatient population. The only randomized trial directly comparing acupuncture to a control in the available evidence [7]A1b enrolled 60 participants (median age 47 years, IQR 39-63; 63% women) with chronic nonspecific low back pain (NSLBP). The setting was outpatient; interventions (acupuncture, chiropractic, waitlist) were delivered in a clinical research environment. Pain severity was not detailed in the abstract, but disability was assessed using the Oswestry Disability Index (ODI). By definition, NSLBP excludes specific causes such as disc herniation, radiculopathy, spinal stenosis, or prior surgery. Broader CLBP trials of other interventions (e.g., [8]A1b[9]A1b[13]A1b[14]A1b) recruit similar community-dwelling adults, but the acupuncture-specific population is limited to this single trial. Clinicians should note that patients with identifiable structural pathology were not represented in the acupuncture evidence.
Pearl: When considering acupuncture for a patient with CLBP, confirm that they meet the nonspecific low back pain definition used in the trial, specifically, no radicular symptoms, no disc herniation on imaging, and no prior lumbar surgery.
Intervention vs. Comparator — Efficacy
- ▸Meta‑analysis shows acupuncture reduces pain vs. no intervention (MD -1.21 at 2 weeks) and vs. usual care (MD -1.35 at 3 months), but certainty is low to very low.
- ▸Multiple RCTs find no significant difference between acupuncture and sham for pain (e.g., electroacupuncture in the elderly and a general CLBP trial).
- ▸Short‑term benefits are seen in some trials (trigger‑point, discogenic sciatica, hand‑pressed pellet), but long‑term effects are not established.
Building on the population profile, the efficacy of acupuncture for chronic low back pain (CLBP) is evaluated across multiple comparators. A 2023 WHO‑commissioned systematic review of 37 RCTs found that, compared with no intervention, acupuncture reduced pain at 2 weeks (MD -1.21, 95% CI -1.50 to -0.92) and 3 months (MD -1.56, 95% CI -2.80 to -0.95) and reduced functional limitations at 2 weeks (SMD -1.39, 95% CI -2.00 to -0.77) and 3 months (SMD -0.57, 95% CI -0.92 to -0.22) [2]A1c. Versus usual care, acupuncture also reduced pain (MD -1.35, 95% CI -1.86 to -0.84) and functional limitations (MD -2.55, 95% CI -3.70 to -1.40) at 3 months [2]A1c. However, the certainty of evidence was low or very low across all outcomes [2]A1c. Compared with sham, only a small improvement in health‑related quality of life (physical) was seen at 6 months (SMD 0.20, 95% CI 0.07 to 0.32) [2]A1c.
Several pivotal RCTs provide mixed results. In a triple‑blind trial of 125 older adults with CLBP, electroacupuncture at any frequency was not superior to manual acupuncture or placebo for pain relief [15]A1b. A separate double‑blind trial of 121 adults found no statistically significant difference between real and sham electroacupuncture in change of PROMIS pain intensity T‑score after 6 weeks (12 sessions) [16]A1b. In contrast, acupuncture for chronic discogenic (12 sessions over 4 weeks) produced a statistically significant greater reduction in leg pain VAS (between‑group difference -7.28 mm, 95% CI -13.76 to -0.80; p = 0.029), exceeding the minimal clinically important difference of 5 mm [21]A1b. Trigger‑point acupuncture improved pain and disability at 4 weeks versus waiting list (VAS p = 0.036; ODI p = 0.029) but not at 8 weeks [22]A1b. Hand‑pressed pellet therapy (6 weeks) reduced VAS significantly (F = 60.522) and improved pain pressure threshold [23]A1b.
| Comparator | Outcome | Effect size (95% CI) | Time point | Certainty |
|---|---|---|---|---|
| No intervention | Pain (0-10) | MD -1.21 (-1.50, -0.92) | 2 weeks | Low [2]A1c |
| No intervention | Pain | MD -1.56 (-2.80, -0.95) | 3 months | Low [2]A1c |
| Usual care | Pain | MD -1.35 (-1.86, -0.84) | 3 months | Low [2]A1c |
| Sham acupuncture | Leg pain VAS (mm) | -7.28 mm (-13.76, -0.80) | 4 weeks | Moderate [21]A1b |
Contradictions and Heterogeneity: The WHO meta‑analysis concluded that there was little or no difference between needling therapies and comparators across most outcomes, with only possible benefits in certain domains [2]A1c. Several high‑quality trials found no superiority of acupuncture over sham [15]A1b[16]A1b. The positive findings in [21]A1b and [23]A1b are limited to short‑term follow‑up and small samples. Thus, while acupuncture may offer modest short‑term pain reduction (≈1-2 points on a 0-10 scale), the evidence is inconsistent and of low certainty.
Pearl: Acupuncture’s benefits for CLBP are small and inconsistently superior to sham; any short‑term pain relief (≈1-2/10) must be weighed against the low certainty of evidence and the possibility of a placebo response.
| Comparator | Outcome | Effect size (95% CI) | Time point | Certainty |
|---|---|---|---|---|
| No intervention | Pain (0-10) | MD -1.21 (-1.50, -0.92) | 2 weeks | Low [2]A1c |
| No intervention | Pain | MD -1.56 (-2.80, -0.95) | 3 months | Low [2]A1c |
| Usual care | Pain | MD -1.35 (-1.86, -0.84) | 3 months | Low [2]A1c |
| Sham acupuncture | Leg pain VAS (mm) | -7.28 mm (-13.76, -0.80) | 4 weeks | Moderate [21]A1b |
| Sham acupuncture | PROMIS pain T‑score | Not significant | 6 weeks | High [16]A1b |
Safety and Harms
- ▸Serious adverse events attributable to acupuncture for chronic low back pain occur in <1% of patients, based on the largest pragmatic trial in older adults [28].
- ▸No serious adverse events were reported in a randomized trial of auricular point acupressure [27].
- ▸The certainty of evidence for harms is low to very low due to inconsistent capture of adverse events across trials [2]; minor transient side effects are poorly quantified.
The evidence base consistently indicates that acupuncture is associated with a low rate of serious adverse events when used for chronic low back pain. The largest pragmatic trial in older adults, the BackInAction trial, reported that rates of serious adverse events were low and similar across the standard acupuncture, enhanced acupuncture, and usual medical care groups, with less than 1% of events possibly related to the acupuncture intervention [28]A1b. In a separate trial of auricular point acupressure (APA) in older adults, no serious adverse events were reported [27]A1b. The WHO-commissioned systematic review by Yu et al. rated the certainty of evidence for harms as low to very low, reflecting sparse systematic reporting of adverse events across 37 RCTs [2]A1c; however, no signal of increased harm from needling therapies was identified. Minor transient side effects such as bruising, soreness, or minor bleeding at needle sites are common clinical observations but were not consistently captured or reported in these trials. No study reported an NNH for any adverse event, as comparative event rates were too low or absent to calculate. Overall, acupuncture appears safe, but the quality of harm reporting limits the precision of this conclusion.
Pearl: The certainty of evidence for harms is low to very low due to inconsistent capture of adverse events across trials [2]A1c; minor transient side effects are poorly quantified.
Certainty of Evidence and Limitations
- ▸Certainty of evidence is low to very low for most outcomes [2][36], driven by performance bias and imprecision.
- ▸Moderate evidence for short-term pain reduction vs sham [34] is offset by high heterogeneity in functional outcomes and conflicting GRADE ratings across reviews.
- ▸Disagreements between meta-analyses (little vs meaningful benefit) reflect differences in inclusion criteria and comparator definitions [2][4].
Despite the favorable safety profile, the certainty of evidence for acupuncture's efficacy is constrained by methodological limitations. The Cochrane review [36]B2a and WHO-commissioned review [2]A1c both rated the evidence as low to very low across all outcomes, primarily due to risk of performance bias (inability to blind acupuncturists), imprecision (wide confidence intervals), and inconsistency. For example, pain relief versus sham did not reach the clinically important threshold of 15 points on a 0-100 scale (mean difference -9.22, 95% CI -13.82 to -4.61) [36]B2a. Function outcomes showed substantial heterogeneity immediately (I²=79%) and at follow-up (I²=87%) [34]B2a. In contrast, one review [34]B2a reported moderate evidence for short-term pain reduction (SMD -0.40, 95% CI -0.54 to -0.25), but this rating conflicts with the low-certainty assessments of larger, more recent meta-analyses [2]A1c[36]B2a. The WHO review [2]A1c found little to no difference between needling therapies and sham across most outcomes, while a Bayesian NMA [4]B2a concluded verum acupuncture is more effective than sham, highlighting how differences in network structure and comparator definitions drive divergent conclusions. Publication bias was not formally assessed in most included reviews. These uncertainties should inform clinical application (see Practice Implication).
Pearl: The evidence for acupuncture in chronic low back pain is consistently downgraded for performance bias and heterogeneity; clinicians should not assume effect sizes from sham-controlled meta-analyses translate directly to pragmatic care.
Practice Implication
- ▸Acupuncture is recommended as a first-line nonpharmacologic treatment for chronic low back pain by ACP (strong recommendation, moderate-quality evidence) and OPTIMa guidelines.
- ▸Clinicians should integrate acupuncture early in management alongside exercise and education.
- ▸Acupuncture offers a safe, guideline-endorsed option that may reduce the need for pharmacotherapy.
Despite residual uncertainty regarding the magnitude of effect beyond placebo, current guidelines uniformly position acupuncture as a first-line nonpharmacologic option for chronic LBP [1]A1c[37]A1c. Clinicians should offer acupuncture early, alongside exercise and education, as part of a multimodal approach. Pearl: Offer acupuncture early in chronic LBP, it is guideline-endorsed, safe, and may reduce reliance on pharmacotherapy.
Pearl: Acupuncture offers a safe, guideline-endorsed option that may reduce the need for pharmacotherapy.
References
- [1]
Qaseem A, Wilt TJ, McLean RM et al.. “Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.” Annals of internal medicine (2017). PMID: 28192789 ↗
L2GUIDELINECited in: Clinical Bottom Line, Practice Implication - [2]
Yu H, Wang D, Verville L et al.. “Systematic Review to Inform a World Health Organization (WHO) Clinical Practice Guideline: Benefits and Harms of Needling Therapies for Chronic Primary Low Back Pain in Adults.” Journal of occupational rehabilitation (2023). PMID: 37991648 ↗
L2GUIDELINECited in: Clinical Bottom Line, Intervention vs. Comparator — Efficacy, Safety and Harms, Certainty of Evidence and Limitations - [3]
Glazov G, Yelland M, Emery J. “Low-level laser therapy for chronic non-specific low back pain: a meta-analysis of randomised controlled trials.” Acupuncture in medicine : journal of the British Medical Acupuncture Society (2016). PMID: 27207675 ↗
L1SR_MA_RCTCited in: Clinical Bottom Line, Safety and Harms - [4]
Baroncini A, Maffulli N, Eschweiler J et al.. “Acupuncture in chronic aspecific low back pain: a Bayesian network meta-analysis.” Journal of orthopaedic surgery and research (2022). PMID: 35725480 ↗
L2SR_OBSCited in: Clinical Bottom Line, Certainty of Evidence and Limitations - [5]
Wu LC, Weng PW, Chen CH et al.. “Literature Review and Meta-Analysis of Transcutaneous Electrical Nerve Stimulation in Treating Chronic Back Pain.” Regional anesthesia and pain medicine (2018). PMID: 29394211 ↗
L2SR_OBSCited in: Clinical Bottom Line, Certainty of Evidence and Limitations - [6]
Li C, Pei Q, Chen Y et al.. “The response-time relationship and covariate effects of acupuncture for chronic pain: A systematic review and model-based longitudinal meta-analysis.” European journal of pain (London, England) (2020). PMID: 32533885 ↗
L2SR_OBSCited in: Clinical Bottom Line, Certainty of Evidence and Limitations - [7]
Tomita N, Croteau D, Roy-Cardinal MH et al.. “Quantitative ultrasound evaluation of the thoracolumbar fascia after manual and acupuncture therapies: an exploratory mechanistic randomized controlled trial with a sequential within-subject phase.” European radiology experimental (2026). PMID: 42319630 ↗
L1RCTCited in: Population and Setting, Safety and Harms - [8]
Lechauve JB, Dobija L, Pereira B et al.. “Evaluation of the Impact of a Smartphone App on Adherence to an Exercise Program in People With Chronic Low Back Pain: Randomized Controlled Trial.” JMIR mHealth and uHealth (2026). PMID: 42296544 ↗
L1RCTCited in: Population and Setting - [9]
Alahmri F, Alkhawajah HA, Nuhmani S et al.. “Effectiveness of telerehabilitation in managing chronic low back pain: a pragmatic randomized controlled non-inferiority trial.” International journal of medical informatics (2026). PMID: 42284831 ↗
L1RCTCited in: Population and Setting - [10]
Koetsier E, Engel H, Maino P et al.. “Percutaneous Intradiscal Hydrogel Implantation Versus Sham Control for Chronic Discogenic Low Back Pain: A Randomized Controlled Double-Blind Trial.” Pain physician (2026). PMID: 42263312 ↗
L1RCTCited in: Population and Setting - [11]
Hashem EY, Habib MN, Elkaradawy S et al.. “High-Voltage Fluoroscopic Guided Pulsed Radiofrequency Compared to Standard-Voltage Pulsed Radiofrequency on the Dorsal Root Ganglion for Chronic Lumbosacral Radicular Pain: A Double-Blinded, Randomized Controlled Trial.” Pain physician (2026). PMID: 42263307 ↗
L1RCTCited in: Population and Setting - [12]
Moor-Smith M, Kozak N, McCue M et al.. “Randomized Controlled Pilot Study of Transcutaneous Electrical Nerve Stimulation for Acute Back Pain in Emergency Department Patients.” The western journal of emergency medicine (2026). PMID: 42258870 ↗
L1RCTCited in: Population and Setting - [13]
Cicuttini FM, Wluka AE, Pan F et al.. “Efficacy of Antibiotics for Chronic Low Back Pain With Disc Herniation: A Randomized Clinical Trial.” JAMA network open (2026). PMID: 42149593 ↗
L1RCTCited in: Population and Setting - [14]
Maddox T, Sackman J, Bonakdar R et al.. “Skill-Based Virtual Reality Therapy in High-Impact Chronic Pain: 2-Year Follow-Up Results From a Secondary Analysis of a Randomized Controlled Trial.” Journal of medical Internet research (2026). PMID: 42061854 ↗
L1RCTCited in: Population and Setting - [15]
Torres SF, de Macedo ACB, Sakai RY et al.. “Effect of Different Frequencies of Electroacupuncture on Chronic Low Back Pain in Older Adults: A Triple-blind, Placebo-controlled, Randomized Clinical Trial.” Pain physician (2023). PMID: 36988362 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [16]
Kong JT, Puetz C, Tian L et al.. “Effect of Electroacupuncture vs Sham Treatment on Change in Pain Severity Among Adults With Chronic Low Back Pain: A Randomized Clinical Trial.” JAMA network open (2020). PMID: 33107921 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [17]
Yeh BY, Liu GH, Lee TY et al.. “Efficacy of Electronic Acupuncture Shoes for Chronic Low Back Pain: Double-Blinded Randomized Controlled Trial.” Journal of medical Internet research (2020). PMID: 33104004 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [18]
Snidvongs S, Taylor RS, Ahmad A et al.. “Facet-joint injections for non-specific low back pain: a feasibility RCT.” Health technology assessment (Winchester, England) (2017). PMID: 29231159 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [19]
Arriaga-Pizano L, Gómez-Jiménez DC, Flores-Mejía LA et al.. “Low back pain in athletes can be controlled with acupuncture by a catecholaminergic pathway: clinical trial.” Acupuncture in medicine : journal of the British Medical Acupuncture Society (2020). PMID: 32429680 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [20]
Liu L, Skinner MA, McDonough SM et al.. “Acupuncture for chronic low back pain: a randomized controlled feasibility trial comparing treatment session numbers.” Clinical rehabilitation (2017). PMID: 28459161 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [21]
Huang Z, Liu S, Zhou J et al.. “Efficacy and Safety of Acupuncture for Chronic Discogenic Sciatica, a Randomized Controlled Sham Acupuncture Trial.” Pain medicine (Malden, Mass.) (2019). PMID: 31369674 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [22]
Liu H, Li YP, Hou MJ et al.. “Effect of trigger point acupuncture on pain and functional activity in patients with chronic non-specific low back pain: a randomised controlled trial.” Acupuncture in medicine : journal of the British Medical Acupuncture Society (2023). PMID: 36760118 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [23]
Park H, Lee H. “Effects of hand-press pellet on pain and daily life of elders with chronic lower back pain: randomized controlled trial.” BMC complementary medicine and therapies (2024). PMID: 38702676 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [24]
Barth J, Muff S, Kern A et al.. “Effect of Briefing on Acupuncture Treatment Outcome Expectations, Pain, and Adverse Side Effects Among Patients With Chronic Low Back Pain: A Randomized Clinical Trial.” JAMA network open (2021). PMID: 34505889 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [25]
Schinhan M, Neubauer B, Pieber K et al.. “Climbing Has a Positive Impact on Low Back Pain: A Prospective Randomized Controlled Trial.” Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine (2016). PMID: 26247548 ↗
L1RCTCited in: Intervention vs. Comparator — Efficacy - [26]
Herman PM, Mann S, DeBar LL et al.. “Cost-Effectiveness of Acupuncture Needling for Older Adults With Chronic Low Back Pain.” Spine (2025). PMID: 41493335 ↗
L1RCTCited in: Safety and Harms - [27]
Lukkahatai N, Wang H, Huang X et al.. “Effects of auricular point acupressure on inflammatory signaling in chronic low back pain: a secondary analysis of a randomized controlled trial.” BMC complementary medicine and therapies (2025). PMID: 41462220 ↗
L1RCTCited in: Safety and Harms - [28]
DeBar LL, Wellman RD, Justice M et al.. “Acupuncture for Chronic Low Back Pain in Older Adults: A Randomized Clinical Trial.” JAMA network open (2025). PMID: 40938602 ↗
L1RCTCited in: Safety and Harms - [29]
Xu R, Yang Y, Yan C et al.. “Dry cupping therapy combined with conventional therapy does not provide additional benefits over conventional therapy alone in patients with non-specific chronic low back pain: a randomized trial.” Chiropractic & manual therapies (2025). PMID: 40524196 ↗
L1RCTCited in: Safety and Harms - [30]
Justice M, Piccorelli A, Avins AL et al.. “Baseline sample characteristics for the BackInAction pragmatic trial of acupuncture for chronic low back pain in older adults.” Contemporary clinical trials (2025). PMID: 40484274 ↗
L1RCTCited in: Safety and Harms - [31]
Kawi J, Yeh CH, Lukkahatai N et al.. “Auricular point acupressure for older adults with chronic low back pain: a randomized controlled trial.” Pain medicine (Malden, Mass.) (2025). PMID: 40152243 ↗
L1RCTCited in: Safety and Harms - [32]
France C, Cook CE, Coffman CJ et al.. “The implementation of a pain navigator program in the department of Veterans Affairs' (VA) health care systems: a cluster randomized pragmatic clinical trial.” Pain medicine (Malden, Mass.) (2024). PMID: 39514873 ↗
L1RCTCited in: Safety and Harms - [33]
Feise RJ, Mathieson S, Kessler RS et al.. “Benefits and harms of treatments for chronic nonspecific low back pain without radiculopathy: systematic review and meta-analysis.” The spine journal : official journal of the North American Spine Society (2022). PMID: 36400393 ↗
L2SR_OBSCited in: Certainty of Evidence and Limitations - [34]
Xiang Y, He JY, Tian HH et al.. “Evidence of efficacy of acupuncture in the management of low back pain: a systematic review and meta-analysis of randomised placebo- or sham-controlled trials.” Acupuncture in medicine : journal of the British Medical Acupuncture Society (2019). PMID: 31526013 ↗
L2SR_OBSCited in: Certainty of Evidence and Limitations - [35]
Dach F, Ferreira KS. “Treating myofascial pain with dry needling: a systematic review for the best evidence-based practices in low back pain.” Arquivos de neuro-psiquiatria (2023). PMID: 38157883 ↗
L2SR_OBSCited in: Certainty of Evidence and Limitations - [36]
Mu J, Furlan AD, Lam WY et al.. “Acupuncture for chronic nonspecific low back pain.” The Cochrane database of systematic reviews (2020). PMID: 33306198 ↗
L2SR_OBSCited in: Certainty of Evidence and Limitations - [37]
Wong JJ, Côté P, Sutton DA et al.. “Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.” European journal of pain (London, England) (2016). PMID: 27712027 ↗
L2GUIDELINECited in: Practice Implication